Why Most Clinical Data Never Changes Patient Care
May 26, 2026
A lack of data isn’t the problem in oncology today. Physicians have access to an incredible volume of clinical trials, treatment pathways, biomarkers, and therapy management considerations. The real challenge is applying that data in the clinic.
A lack of data isn’t the problem in oncology today. Physicians have access to an incredible volume of clinical trials, treatment pathways, biomarkers, and therapy management considerations. The real challenge is applying that data in the clinic.
In this episode of Transforming Medical Communications, Wesley Portegies is joined by Ali Al-Hashimi, Director of Global Medical Affairs in Thoracic Oncology at Pfizer, to discuss how Medical Affairs can make evidence more accessible for physicians, pharmacists, and care teams in real-world practice.
We’ll talk about:
- How shadowing physicians reshaped Ali’s entire approach to communication
- Why clinic-friendly should be the new gold standard for how we present data
- What MSLs should actually be asking in their conversations
Cut Through the Noise. Elevate Your Strategy.
Guiding Medical Affairs strategy across Medical Communications, Field Medical, or Medical Affairs Training? Wesley Portegies, host of Transforming Medical Communications, is opening up a few exclusive 30-minute consultancy sessions.
Guiding Medical Affairs strategy across Medical Communications, Field Medical, or Medical Affairs Training? Wesley Portegies, host of Transforming Medical Communications, is opening up a few exclusive 30-minute consultancy sessions.
This is a candid, insight-rich opportunity to step back from the day-to-day, pressure-test your approach, and explore fresh solutions to complex MedComms challenges—from scientific engagement to operational alignment.
If you’re shaping the future of Medical Affairs at your organization, this conversation is for you.
Reserve your session → Schedule now https://mce.global/consultancy
Previous guests include: Sissy Easo-Joseph at GSK, Barbara Bish at Janssen, Drew Provan at Queen Mary University, Rebecca McCracken at Agios Pharmaceuticals
Check out our three most downloaded episodes:
- From Event to Strategy: Making Congresses More Impactful
- Building a Medical Affairs Powerhouse Without a Big Pharma Budget
- The SCP Playbook: Turning Strategy into Real-World Impact
Transforming Medical Communications is handcrafted by our friends over at: fame.so
Disclaimer: The opinions and views expressed by the guest are their own and do not represent any past or current employers.